Literature DB >> 26241016

Fibrosis: Targeting EMT to reverse renal fibrosis.

Susan J Allison.   

Abstract

Entities:  

Year:  2015        PMID： 26241016     DOI： 10.1038/nrneph.2015.133

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  2 in total

1.  Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease.

Authors:  M Teresa Grande; Berta Sánchez-Laorden; Cristina López-Blau; Cristina A De Frutos; Agnès Boutet; Miguel Arévalo; R Grant Rowe; Stephen J Weiss; José M López-Novoa; M Angela Nieto
Journal:  Nat Med       Date:  2015-08-03       Impact factor: 53.440

2.  Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis.

Authors:  Sara Lovisa; Valerie S LeBleu; Björn Tampe; Hikaru Sugimoto; Komal Vadnagara; Julienne L Carstens; Chia-Chin Wu; Yohannes Hagos; Birgitta C Burckhardt; Tsvetelina Pentcheva-Hoang; Hersharan Nischal; James P Allison; Michael Zeisberg; Raghu Kalluri
Journal:  Nat Med       Date:  2015-08-03       Impact factor: 53.440
  2 in total
  16 in total

1.  PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease.

Authors:  Yajuan Li; Qingsong Hu; Chunlai Li; Ke Liang; Yu Xiang; Heidi Hsiao; Tina K Nguyen; Peter K Park; Sergey D Egranov; Chandrashekar R Ambati; Nagireddy Putluri; David H Hawke; Leng Han; Mien-Chie Hung; Farhad R Danesh; Liuqing Yang; Chunru Lin
Journal:  J Clin Invest       Date:  2019-02-11       Impact factor: 14.808

2.  Impairment of PPARα and the Fatty Acid Oxidation Pathway Aggravates Renal Fibrosis during Aging.

Authors:  Ki Wung Chung; Eun Kyeong Lee; Mi Kyung Lee; Goo Taeg Oh; Byung Pal Yu; Hae Young Chung
Journal:  J Am Soc Nephrol       Date:  2018-02-12       Impact factor: 10.121

3.  Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-β signaling in kidney fibroblasts.

Authors:  Yen-Ting Chen; Pei-Yu Jhao; Chen-Ting Hung; Yueh-Feng Wu; Sung-Jan Lin; Wen-Chih Chiang; Shuei-Liong Lin; Kai-Chien Yang
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 4.  Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases.

Authors:  Minyang Fu; Dandan Peng; Tianxia Lan; Yuquan Wei; Xiawei Wei
Journal:  Acta Pharm Sin B       Date:  2022-01-19       Impact factor: 14.903

Review 5.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

6.  Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process.

Authors:  Sugyeong Ha; Ki Wung Chung; Jaewon Lee; Hae Young Chung; Hyung Ryong Moon
Journal:  Arch Pharm Res       Date:  2022-03-25       Impact factor: 4.946

Review 7.  Signalling pathways involved in hypoxia-induced renal fibrosis.

Authors:  Minna Liu; Xiaoxuan Ning; Rong Li; Zhen Yang; Xiaoxia Yang; Shiren Sun; Qi Qian
Journal:  J Cell Mol Med       Date:  2017-01-18       Impact factor: 5.310

8.  Tubule-specific protein nanocages potentiate targeted renal fibrosis therapy.

Authors:  Xuan Zhang; Qian Chen; Liyuan Zhang; Haiping Zheng; Chunjie Lin; Qunfang Yang; Tao Liu; Haigang Zhang; Xiaohong Chen; Lei Ren; Wenjun Shan
Journal:  J Nanobiotechnology       Date:  2021-05-26       Impact factor: 10.435

9.  Effect of Huai Qi Huang on Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells through miR-200a.

Authors:  Jinyun Pu; Yu Zhang; Jianhua Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-14       Impact factor: 2.629

10.  A nationwide survey of clinical characteristics, management, and outcomes of acute kidney injury (AKI) - patients with and without preexisting chronic kidney disease have different prognoses.

Authors:  Heng-Chih Pan; Pei-Chen Wu; Vin-Cent Wu; Ya-Fei Yang; Tao-Min Huang; Chih-Chung Shiao; Te-Chuan Chen; Der-Cherng Tarng; Jui-Hsiang Lin; Wei-Shun Yang; Chiao-Yin Sun; Chan-Yu Lin; Tzong-Shinn Chu; Mai-Szu Wu; Kwan-Dun Wu; Yung-Chang Chen; Chiu-Ching Huang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.